introduction
The orificiel syndrome occurs very frequently in the stomach cancer.
Objectives
The objectives of this work were to study the epidemiological, clinical and therapeutic aspects of the orificiel syndrome in gastric cancer.
Methodology
This was a 15-year retrospective study from 1999 to 2014, including any patient with confirmed gastric cancer in the anatomical pathology with orifice syndrome in the department.
Result
We have collected over a period of15 years(1999-2014),372 orificiel syndrome cases, representing 53.3% of stomach cancers, 29.6% of digestive cancers and 2.1% of hospitalizations. The sex ratio was 1.5; the average age was 56 years with extremes of 27 and 84 years and a standard deviation of 13.3. The average time of evolution of orificiel syndrome was 3.5 weeks with extremes of1 and 6 weeks and a standard deviationof 5.2. 75(seventy five) patients (20.2%) were admitted in emergencies.The main signs found were: vomiting 335/335 cases (100%), dysphagia 37/37 cases (100%) weight loss 364 cases (97.8%), epigastric mass 172 cases(46.5%), fastinglapping 168 cases(45.2%) and ascites105 cases(28.2%). 192 patients were classified as WHO grade III(78.5%); WHOII45 cases(12.1%) and WHOIV 35 cases(9.4%). A large majority of our patients,267 (71.8%), had an ASA score III or more. The pyloricantrum-seat was the most represented 335 cases(90.1%), cardia location in 37cases. Adenocarcinoma was the most common histological type351(94.4%). The operability rate was 75% (282 patients): 46 patients (16.3%) had agastricre section; 184 cases(65.3%) of gastro-enteroanastomosis; 32 cases(11.3%) of feeding stoma; 90patients (24.2%) were not operated. Morbidity was 25.6% and mortality 14.5%. Thefore cast is very poor with a 3-year survival of 4,3%.
Keywords
stomach cancer syndrome orificiel, Bamako Mali.
